Psyence Biomedical (PBM) Other Non Operating Income (2023 - 2025)

Psyence Biomedical's (PBM) quarterly Other Non Operating Income came in at $636.0 in Q3 2025, up 100.64% year-on-year from $316.99 in Q3 2024, and up 100.64% quarter-over-quarter from -$99628.0 in Q3 2024.

Psyence Biomedical (PBM) Other Non Operating Income (2023 - 2025) Analysis & Trends

Psyence Biomedical's Other Non Operating Income history runs 3 years deep, the most recent figure standing at $636.0 for Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Psyence Biomedical 1.56 Mn 1.56 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 636.00
Sep 30, 2024 -99,628.00
Sep 30, 2023 2,776.00